40 related articles for article (PubMed ID: 9192964)
1. EANM guidelines for radionuclide therapy of bone metastases with beta-emitting radionuclides.
Handkiewicz-Junak D; Poeppel TD; Bodei L; Aktolun C; Ezziddin S; Giammarile F; Delgado-Bolton RC; Gabriel M
Eur J Nucl Med Mol Imaging; 2018 May; 45(5):846-859. PubMed ID: 29453701
[TBL] [Abstract][Full Text] [Related]
2. Laser-Ablative Synthesis of Isotope-Enriched Samarium Oxide Nanoparticles for Nuclear Nanomedicine.
Popova-Kuznetsova E; Tikhonowski G; Popov AA; Duflot V; Deyev S; Klimentov S; Zavestovskaya I; Prasad PN; Kabashin AV
Nanomaterials (Basel); 2019 Dec; 10(1):. PubMed ID: 31905619
[TBL] [Abstract][Full Text] [Related]
3. Internal radiation therapy: a neglected aspect of nuclear medicine in the molecular era.
Lin Y
J Biomed Res; 2015 Sep; 29(5):345-55. PubMed ID: 26445567
[TBL] [Abstract][Full Text] [Related]
4. Beyond Palliation: Therapeutic Applications of
Wilky BA; Loeb DM
Clin Exp Pharmacol; 2013 Jun; 3(3):. PubMed ID: 25664221
[TBL] [Abstract][Full Text] [Related]
5. Painful boney metastases.
Smith HS; Mohsin I
Korean J Pain; 2013 Jul; 26(3):223-41. PubMed ID: 23861996
[TBL] [Abstract][Full Text] [Related]
6. Prospective dosimetry with 99mTc-MDP in metabolic radiotherapy of bone metastases with 153Sm-EDTMP.
Bianchi L; Baroli A; Marzoli L; Verusio C; Chiesa C; Pozzi L
Eur J Nucl Med Mol Imaging; 2009 Jan; 36(1):122-9. PubMed ID: 18751975
[TBL] [Abstract][Full Text] [Related]
7. The use of chelated radionuclide (samarium-153-ethylenediaminetetramethylenephosphonate) to modulate phenotype of tumor cells and enhance T cell-mediated killing.
Chakraborty M; Wansley EK; Carrasquillo JA; Yu S; Paik CH; Camphausen K; Becker MD; Goeckeler WF; Schlom J; Hodge JW
Clin Cancer Res; 2008 Jul; 14(13):4241-9. PubMed ID: 18594006
[TBL] [Abstract][Full Text] [Related]
8. The management of painful bone metastases with an emphasis on radionuclide therapy.
Hillegonds DJ; Franklin S; Shelton DK; Vijayakumar S; Vijayakumar V
J Natl Med Assoc; 2007 Jul; 99(7):785-94. PubMed ID: 17668645
[TBL] [Abstract][Full Text] [Related]
9. Radiopharmaceutical therapy of bone metastases with 89SrCl2, 186Re-HEDP and 153Sm-EDTMP: a dosimetric study using Monte Carlo simulation.
Strigari L; Sciuto R; D'Andrea M; Pasqualoni R; Benassi M; Maini CL
Eur J Nucl Med Mol Imaging; 2007 Jul; 34(7):1031-8. PubMed ID: 17237963
[TBL] [Abstract][Full Text] [Related]
10. 153Sm-EDTMP for bone pain palliation in skeletal metastases.
Maini CL; Bergomi S; Romano L; Sciuto R
Eur J Nucl Med Mol Imaging; 2004 Jun; 31 Suppl 1():S171-8. PubMed ID: 15127241
[TBL] [Abstract][Full Text] [Related]
11. A dose-controlled study of 153Sm-ethylenediaminetetramethylenephosphonate (EDTMP) in the treatment of patients with painful bone metastases.
Resche I; Chatal JF; Pecking A; Ell P; Duchesne G; Rubens R; Fogelman I; Houston S; Fauser A; Fischer M; Wilkins D
Eur J Cancer; 1997 Sep; 33(10):1583-91. PubMed ID: 9389919
[TBL] [Abstract][Full Text] [Related]
12. Samarium for osteoblastic bone metastases and osteosarcoma.
Anderson P
Expert Opin Pharmacother; 2006 Aug; 7(11):1475-86. PubMed ID: 16859431
[TBL] [Abstract][Full Text] [Related]
13. Samarium lexidronam (153Sm-EDTMP): skeletal radiation for osteoblastic bone metastases and osteosarcoma.
Anderson P; Nuñez R
Expert Rev Anticancer Ther; 2007 Nov; 7(11):1517-27. PubMed ID: 18020921
[TBL] [Abstract][Full Text] [Related]
14. Dose response relationship and multiple dose efficacy and toxicity of samarium-153-EDTMP in metastatic cancer to bone.
Alberts AS; Smit BJ; Louw WK; van Rensburg AJ; van Beek A; Kritzinger V; Nel JS
Radiother Oncol; 1997 May; 43(2):175-9. PubMed ID: 9192964
[TBL] [Abstract][Full Text] [Related]
15. [Primary investigation of dose-effect relationship of 153Sm-EDTMP in treating multiple bone metastases].
Fan W; Chen LX; Liu XW; Tang Q; Wang GH; Zhi SF; Zeng ZY
Ai Zheng; 2006 Nov; 25(11):1395-8. PubMed ID: 17094908
[TBL] [Abstract][Full Text] [Related]
16. High-dose samarium-153 ethylene diamine tetramethylene phosphonate: low toxicity of skeletal irradiation in patients with osteosarcoma and bone metastases.
Anderson PM; Wiseman GA; Dispenzieri A; Arndt CA; Hartmann LC; Smithson WA; Mullan BP; Bruland OS
J Clin Oncol; 2002 Jan; 20(1):189-96. PubMed ID: 11773169
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
